Pooled safety and efficacy analysis of trifluridine/tipiracil plus bevacizumab in five clinical trials using individual data from patients with metastatic colorectal cancer

ABSTRACT: Primary outcome(s): Incidence of adverse events Response to treatment Disease control rate Objective response rate Overall survival Progression free survival Time to treatment failure

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 2656330 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR